Genisca, Alicia

Genisca, Alicia was paid $791K by Medicaid between Sep 2018 and Dec 2024, across 6 billing codes. Its largest line is 99283, emergency room visit (moderate) — 61% of everything it billed.

33Billing provider infoGENISCA, ALICIA
PROVIDENCE, RI 02903

33aNPI1235369554assigned 07/21/2009

33bProvider typePediatrics Physician

28Total paid$791K

24GClaims4,613

24DCodes billed6

24AFirst – last monthSep 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Rhode Island

Rank by total paid#27 of 265

Median peer was paid$133K

This provider vs. median6.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	305	$32K
2019	576	$66K
2020	918	$169K
2021	1,108	$192K
2022	618	$131K
2023	845	$156K
2024incomplete	243	$44K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	61%	2,426	2,367	$483K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	23%	1,452	1,432	$179K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.8%	363	349	$70K
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.5%	304	229	$52K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	56	54	$7K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	12	12	$360.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.